SOLACI-CACI 2021 | PICS-AICS Session

✔️ Watch the PICS-AICS session in the SOLACI-CACI 2021 Congress.

👨‍🏫 Program:

  • 02:07 – Initial Experience with Myvalve in Pulmonary Position – Carlos Pedra
  • 17:54 – Mid-Term Follow-Up of Patients with Venus P Valve in LATAM – Francisco Garay
  • 32:24 – New Insights in Tricuspid Valve Replacement – Raúl Arrieta
  • 45:49 – Early Results with Pulsta Valve Replacement in Argentina – Alejandro Peirone
  • 01:00:37 – What is the Limit for Edward Sapien Valve Implantation? – Ahmet Çelebi

👉🏻 Moderators: Ziyad Hijazi & Damien Kenny
👉🏻 Panelists: Aguirre, Daniel – Alonso, José – Damsky Barbosa, Jesús – Rossi, Raúl – Zabal, Carlos.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

TCT 2024 – EVOLVED trial: Early Intervention for Patients with Severe Asymptomatic Aortic Stenosis and Myocardial Fibrosis?

Treating symptomatic severe aortic stenosis (AS) with aortic valve replacement is currently considered a class I recommendation, evidence level B, according to the current...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...